focuses his practice on real estate, corporate, foreign investments and M&A transactions, with about 25 years of experience. He acts as counsel for several Italian pharmaceutical companies doing business in Mexico, including Alfasigma, Recordati Rare Diseases, Kedrion and SIFI. He has been involved and has acted as leading counsel in many strategic transactions in Mexico, some of them for several hundred million dollars, including the sales of insurance companies, hotel chains and large retail spaces. He is member of the board or secretary in several Mexican companies, some of which are listed on the Mexican Stock Exchange.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.